Autologous Tumor Infiltrating Lymphocytes ITIL-168
autologous tumor infiltrating lymphocytes itil-168
"A preparation of autologous tumor infiltrating lymphocytes (TILs) derived from each patient's digested and cryopreserved tumor, with potential immunomodulating and antineoplastic activities. Upon administration back into the patient, the autologous TILs ITIL-168 specifically recognize and kill the patient's tumor cells."